|  | Tumour | Muscle | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient | Clinical | Baseline | After 8–10# CRT | % Changes | Baseline | After 8–10# CRT | % changes | ||||||
Number | Response | F | Ka | F | Ka | F | Ka | F | Ka | F | Ka | F | Ka |
P1 | Poor | 0.588 | 1.380 | 0.294 | 1.188 | −50 | −14 | 0.144 | 0.018 | 0.570 | 0.864 | 296 | 4700 |
P2 | Good | 1.428 | 1.578 | 2.472 | 0.702 | 73 | −56 | 0.102 | 0.042 | 0.672 | 1.434 | 559 | 3314 |
P3 | Poor | 3.198 | 0.912 | 2.484 | 0.696 | −22 | −24 | 0.120 | 0.018 | 0.600 | 0.360 | 400 | 1900 |
P4 | Poor | 4.410 | 0.630 | 3.132 | 0.702 | −29 | 11 | 0.126 | 0.024 | 0.600 | 0.360 | 376 | 1400 |
P5 | Good | 6.702 | 0.924 | 4.380 | 0.720 | −35 | −22 | 0.138 | 0.006 | 0.600 | 0.360 | 335 | 5900 |
P6 | Poor | 6.702 | 0.924 | – | – | – | – | 0.600 | 0.444 | – | – | – | – |
P7 | Good | 3.942 | 0.924 | 4.656 | 0.618 | 18 | −33 | 0.174 | 0 | 0.054 | 1.116 | −69 | n.d. |
P8 | Poor | 4.368 | 0.870 | 0.750 | 0.312 | −83 | −64 | 0.078 | 4.806 | 0.348 | 2.058 | 346 | −57 |
P9 | Poor | 4.248 | 0.714 | 0.756 | 0.096 | −82 | −87 | 0.084 | 0.036 | 0.480 | 1.056 | 471 | 2833 |
P10 | Good | – | – | – | – | – | – | – | – | – | – | – | – |
P11 | Good | 2.526 | 0.762 | 6.192 | 0.720 | 145 | −6 | 0.114 | 0.006 | 0.600 | 0.366 | 426 | 6000 |
Median |  | 4.100 | 0.920 | 2.480 | 0.700 | −28.980 | −23.680 | 0.120 | 0.020 | 0.600 | 0.860 | 376.190 | 3073.810 |
IQR | Â | 1.710 | 0.140 | 3.620 | 0.100 | 68.110 | 41.600 | 0.040 | 0.030 | 0.120 | 0.760 | 91.530 | 3225.000 |